Searched for
DIMETHYL FUMARATE
Rakesh Jhunjhunwala, LIC hiked stake in this pharma company in Q2Total holdings of mutual fund houses in the company also increased to 12.58 per cent from 11.94 per cent on a quarter-on-quarter basis, dat...- Glenmark Pharma gets USFDA nod to market drug for relapsing multiple sclerosisDrug major Glenmark Pharma said it has received final approval from the US health regulator for Dimethyl Fumarate delayed-release capsules,...
- Stocks in the news: RIL, LVB, Vodafone Idea, Dr Reddy’s Labs, Mindtree and Sun PharmaDr Reddy's Laboratories on Saturday said it has launched Dimethyl Fumarate delayed-release capsules, used to treat multiple sclerosis (MS),...
- Dr Reddy's launches generic drug to treat multiple sclerosis in USThe company's product is a therapeutic equivalent generic version of Biogen's Tecfidera delayed-release capsules, the Hyderabad-based drug ...
- Zydus Cadila gets US health regulator nod for multiple sclerosis treatment drugZydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Dimethyl Fumarate delayed re...
- Glenmark gets tentative nod from USFDA for generic multiple sclerosis treatment drugThese are generic version of Tecfidera Capsules, 120 mg and 240 mg, of Biogen Inc.
- Shilpa Medicare gets tentative USFDA nod for multiple sclerosis drugThe company's abbreviated new drug application (ANDA) for Dimethyl Fumarate delayed release capsules in the strengths of 120 mg and 240 mg ...
Load More